Jaime Darce

Jaime Darce has a Ph.D. in Immunology from Mayo Clinic College of Medicine. They have held various roles in companies such as Tectonic Therapeutic, Inc., Flagship Labs, and Bluefin Biomedicine, with expertise in pharmacology, immunology, target & drug discovery, and antibody technologies. Their research contributions include discovering the effects of mutations in the FoxP3 transcription factor on autoimmune diabetes and inflammatory arthritis, as well as collaboration in identifying specific commensal bacteria exacerbating arthritis disease. Before that, they were a post-doctoral research fellow at Harvard Medical School. Prior to that, they completed a B.S. in Microbiology and Immunology at the University of Miami.